Thomas T. MacDonald

Active 1975–2022

140
Papers
25,400
Citations
95
h-index
140
i10-index

Citations

Citations per year for Thomas T. MacDonald1970: 1 citations1974: 1 citations1976: 2 citations1977: 4 citations1978: 4 citations1979: 8 citations1980: 2 citations1981: 3 citations1982: 4 citations1984: 3 citations1985: 6 citations1986: 6 citations1987: 9 citations1988: 9 citations1989: 15 citations1990: 29 citations1991: 35 citations1992: 37 citations1993: 63 citations1994: 29 citations1995: 53 citations1996: 42 citations1997: 97 citations1998: 101 citations1999: 146 citations2000: 170 citations2001: 146 citations2002: 175 citations2003: 148 citations2004: 142 citations2005: 184 citations2006: 214 citations2007: 217 citations2008: 233 citations2009: 238 citations2010: 253 citations2011: 292 citations2012: 292 citations2013: 283 citations2014: 300 citations2015: 273 citations2016: 262 citations2017: 229 citations2018: 284 citations2019: 748 citations2020: 760 citations2021: 816 citations2022: 643 citations2023: 490 citations2024: 681 citations2025: 285 citations2026: 8 citations1971–1973: no citations, so these years are not shown1975: no citations, so this year is not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,481 citing papers, 23.3% of this breakdownChina: 1,430 citing papers, 13.4% of this breakdownUnited Kingdom: 883 citing papers, 8.3% of this breakdownGermany: 654 citing papers, 6.2% of this breakdownItaly: 599 citing papers, 5.6% of this breakdownCanada: 423 citing papers, 4% of this breakdownFrance: 401 citing papers, 3.8% of this breakdownJapan: 337 citing papers, 3.2% of this breakdownNetherlands: 260 citing papers, 2.4% of this breakdownAustralia: 223 citing papers, 2.1% of this breakdownSpain: 189 citing papers, 1.8% of this breakdownSwitzerland: 179 citing papers, 1.7% of this breakdown
0%23.3%Other 24.2%

Fields

  • Biochemistry, Genetics and Molecular Biology40%
  • Medicine26.6%
  • Immunology and Microbiology21%
  • Neuroscience4%
  • Agricultural and Biological Sciences2.7%
  • Nursing2.3%
  • Other3.4%

Topics

  • Inflammatory Bowel Disease6.8%
  • Gut microbiota and health6%
  • Immune Cell Function and Interaction4.1%
  • IL-33, ST2, and ILC Pathways3.2%
  • T-cell and B-cell Immunology2.8%
  • Microscopic Colitis2.4%
  • Other74.7%

Coauthors

All papers

Open in search
  1. Homeostasis of the gut barrier and potential biomarkers

    Authors: , , , , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2016 cited by 615

  2. Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract

    Authors: , , , , , , , , - Gastroenterology 2011 cited by 645

  3. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

    Authors: , , , , , , , , , , , - Oncogene 2014 cited by 603

  4. Can probiotics modulate human disease by impacting intestinal barrier function?

    Authors: , , , , , , , - British Journal Of Nutrition 2017 cited by 485

  5. Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert R. Singhaus, Helen H. Sun, Barbara A. Swift, Rachel D. Totoritis, Anna Vossenkämper, Paris Ward, David D. Wisnoski, Daohua Zhang, Robert W. Marquis, Peter J. Gough, John Bertin - Journal of Medicinal Chemistry 2017 cited by 475

  6. Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Communications Biology 2020 cited by 221

  7. Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 132

  8. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miriam Mérad, Régis Josien, Sophie Brouard, Jean‐Paul Soulillou, Gilles Blancho, Arnaud Bourreille, Philippe Naveilhan, Bernard Vanhove, Nicolas Poirier - Journal of Clinical Investigation 2019 cited by 133

  9. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications

    Authors: , , , , , , , , , , - Scandinavian Journal of Gastroenterology 2016 cited by 173

  10. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 154

  11. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells

    Authors: , , , , , , - Laboratory Investigation 2005 cited by 480

  12. Immunity, Inflammation, and Allergy in the Gut

    Authors: , - Science 2005 cited by 1,036

  13. The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation

    Authors: , , , , , , , , , , , , , , , - Cellular and Molecular Gastroenterology and Hepatology 2018 cited by 120

  14. Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn’s disease strictures

    Authors: , , , , , , , , , , , , - Gut 2009 cited by 206

  15. Developing in vitro expanded CD45RA+regulatory T cells as an adoptive cell therapy for Crohn's disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Gut 2015 cited by 194

  16. Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studies

    Authors: , , - British Journal Of Nutrition 2010 cited by 461

  17. The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

    Authors: , , , , , , , , , , , , - Fibrogenesis & Tissue Repair 2013 cited by 103

  18. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease

    Authors: , , , , , - Journal of Clinical Investigation 2001 cited by 580

  19. Characterisation of Acute Murine Dextran Sodium Sulphate Colitis: Cytokine Profile and Dose Dependency

    Authors: , , , , , - Digestion 2000 cited by 382

  20. Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2015 cited by 127

  21. Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut

    Authors: , , , , , , , , , , , , , , , - Mucosal Immunology 2014 cited by 96

  22. Regulation of Homeostasis and Inflammation in the Intestine

    Authors: , , , - Gastroenterology 2011 cited by 263

  23. Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease

    Authors: , , , , , , , , , , , , - Scientific Reports 2021 cited by 32

  24. The IL-33/ST2 axis: Role in health and disease

    Authors: , , - Cytokine & Growth Factor Reviews 2015 cited by 175